Weider, E., Susan-Resiga, D., Essalmani, R., Hamelin, J., Asselin, M., Nimesh, S., . . . Seidah, N. G. (2016). Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Single Domain Antibodies Are Potent Inhibitors of Low Density Lipoprotein Receptor Degradation. J Biol Chem.
Chicago-tyylinen lähdeviittausWeider, Elodie, et al. "Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Single Domain Antibodies Are Potent Inhibitors of Low Density Lipoprotein Receptor Degradation." J Biol Chem 2016.
MLA-viiteWeider, Elodie, et al. "Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Single Domain Antibodies Are Potent Inhibitors of Low Density Lipoprotein Receptor Degradation." J Biol Chem 2016.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.